Inflation Signs Amid Froth Top Sonders’ Stock Worries
This article is for subscribers only.
When a doctor gets the bloodwork back and says all the test results were fine, many of us won’t even bother listening to the numbers that follow. If there’s a problem, however, we’ll be sure to walk out of the office knowing exactly what the tests show for cholesterol or triglycerides or whatever the issue is.
In diagnosing U.S. stocks, Liz Ann Sonders generally has given the all-clear sign during the rally in equities over the past five years. So while she continues to believe the U.S. is still in the “middle innings” of a secular bull market, it’s worth listening when the chief investment strategist at Charles Schwab Corp. talks about a few results in the bloodwork that may signal some short-term sickness.